For decades, the standard of care for women diagnosed with vulvar cancer involving the clitoris has been focused exclusively on oncological survival—the total eradication of the malignancy. While these life-saving procedures were successful in terms of cancer clearance, they often resulted in permanent anatomical loss and a significant decline in sexual function and overall quality of life.
Now, a team of medical pioneers at Radboud University Medical Center (Radboudumc) in the Netherlands has unveiled a groundbreaking surgical technique that restores the clitoris after tumor removal. This development marks a long-overdue advancement in reconstructive gynecologic surgery, finally narrowing the gender gap in sexual health preservation that has persisted for nearly 40 years.
The Core Innovation: Restoring Function and Form
The newly developed procedure is a collaborative effort between gynecologic oncologist Mieke ten Eikelder and plastic surgeon Tim Nijhuis. At its heart, the technique focuses on both anatomical reconstruction and nerve preservation.
"When the tumor is located in or around the clitoris, we sometimes have to remove part of it," explains Dr. Ten Eikelder. "Until now, the clinical standard was to simply close the wound, leaving the clitoris buried beneath a layer of scar tissue. Little to no attention was paid to the patient’s long-term quality of life or whether sexual function, specifically the ability to reach orgasm, would remain possible."
The surgical process involves a meticulous two-stage approach. Once the oncological team has successfully resected the tumor, the plastic surgery team intervenes. They carefully isolate the remaining nerve bundles, repositioning them to form a functional clitoral tip. To cover the reconstruction, surgeons utilize a graft of buccal mucosa—tissue harvested from the inside of the cheek. This tissue is physiologically similar to that of the vulva, making it an ideal candidate for integration, as it allows for the retention of sensory pathways while facilitating natural healing.
A Historical Disparity: The 40-Year Gap
The medical community has long recognized the importance of reconstructive surgery for male patients. The first successful penile reconstruction surgery occurred in 1987, providing a roadmap for restoring both form and function in the wake of trauma or malignancy. Despite this, the development of an equivalent procedure for women faced systemic neglect for decades.
This delay is often attributed to a historical lack of research funding and societal stigma surrounding female sexual health. However, the work of Ten Eikelder and Nijhuis represents a paradigm shift. By applying advanced microsurgical techniques to the female anatomy, the team has successfully bridged a 40-year gap in gender-specific reconstructive medicine.
Supporting Data: Initial Patient Outcomes
The preliminary results from the initial study group are, by all accounts, highly encouraging. Out of the first 23 women to undergo the procedure, an impressive 90% reported the ability to achieve a clitoral orgasm following surgery.
Recovery Timeline and Sensory Restoration
The recovery process is generally swift, with patients typically regaining sexual function within three to six months post-operation. Dr. Ten Eikelder notes that the sensory experience evolves over the first year:
- Early Phase (0–3 months): Patients may report hypersensitivity or temporary numbness as the nerves recalibrate.
- Mid Phase (3–6 months): Most patients begin to report the return of pleasure-centered sensations, with many achieving orgasm.
- Long-term (12+ months): Recovery typically stabilizes, with the majority of patients reporting a return to baseline sensation levels comparable to their pre-cancer diagnosis.
These metrics suggest that the 15-minute addition to the surgical time—a marginal increase in the grand scheme of an oncological procedure—yields disproportionately positive outcomes for patient psychological and physical well-being.
Implications: Beyond Cancer Treatment
While the primary application of this technique is within the field of gynecologic oncology, the implications for reconstructive medicine are vast. The research team is already looking toward broader applications, most notably for survivors of female genital mutilation (FGM).
For the estimated 450 women diagnosed with vulvar cancer in the Netherlands each year—one-quarter of whom face potential clitoral involvement—this technique offers a new sense of autonomy and identity. By integrating this procedure into standard care, the medical field is moving away from the "survival-only" model toward a more holistic "survivorship" model, where the patient’s quality of life is considered as essential as the pathology report.
National Rollout and Scientific Cooperation
Recognizing the potential for this technique to become the new global standard, Radboudumc has initiated a nationwide scientific research program. The protocol is currently being expanded to eight additional hospitals across the Netherlands.
A Multidisciplinary Training Model
The transition from a specialized procedure to a standard of care requires rigorous training. Under the guidance of Ten Eikelder and Nijhuis, specialized gynecologic oncologists and plastic surgeons are undergoing intensive training to standardize the technique. Furthermore, the duo has begun hosting international workshops to train specialists from across the globe, ensuring that the benefits of this innovation are not confined to Dutch borders.
Future Directions and Research
Despite the success of the initial cohort, the researchers remain cautious and committed to evidence-based medicine. They emphasize that while the early results are promising, long-term follow-up is necessary to ensure the technique is as safe and effective for the general population as it was for the initial study group.
Financial and Clinical Integration
The Dutch Cancer Society has provided essential financial backing to support this ongoing research. Future studies will focus on two key areas:
- Quantitative Quality of Life Assessments: Utilizing standardized psychosexual health surveys to measure improvements in sexual function and patient-reported outcomes.
- Safety and Scalability: Determining how the technique can be integrated into the diverse workflows of different hospitals without compromising oncological safety.
Conclusion: A New Chapter in Gynecologic Health
The innovation pioneered at Radboudumc is a testament to the power of asking the "right" questions in medicine. For too long, the focus in cancer care was limited to the removal of the disease. By integrating the perspectives of plastic surgery and oncology, the team has demonstrated that it is possible to treat the cancer without sacrificing the essence of the patient’s sexual identity.
As this technique gains traction, the medical community hopes that it will foster a broader conversation about sexual health in cancer survivors. By restoring the clitoris, these surgeons are not just performing a repair; they are restoring a fundamental aspect of the human experience. With the support of international health bodies and continued rigorous scientific inquiry, this new surgical technique stands to change the lives of thousands of women for generations to come.
References and Further Information
- For detailed results of the initial study, refer to the full article published in the Gynecologic Oncology Journal.
- For further inquiries regarding the surgical training program or the research protocol, please contact the press office at Radboud University Medical Center.
About the Author
